The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1699-3055
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer ; day:6 ; month:10 ; year:2022 ; pages:1-12
Clinical and translational oncology ; (6.10.2022), 1-12
- Creator
-
Li, Liuxun
Xu, Jiangli
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-022-02957-x
- URN
-
urn:nbn:de:101:1-2022122509101633678048
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Liuxun
- Xu, Jiangli
- SpringerLink (Online service)
Other Objects (12)
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen regulation of the androgen receptor coregulators
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen regulation of the androgen receptor coregulators
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen regulation of the androgen receptor coregulators
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice